Clinical Trials Directory

Trials / Conditions / FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma

FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma

8 registered clinical trials studyying FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingOutcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective,
NCT06689956
Mayo Clinic—
Active Not RecruitingRemote Home-Based Exercise Program for Strength Training in Endometrial Cancer Survivors in Rural Areas
NCT06213571
Mayo ClinicN/A
Active Not RecruitingTesting the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate
NCT05538897
National Cancer Institute (NCI)Phase 1 / Phase 2
Active Not RecruitingA Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With
NCT04092270
National Cancer Institute (NCI)Phase 1
CompletedExemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepitheli
NCT03300557
National Cancer Institute (NCI)Phase 2
CompletedMedroxyprogesterone Acetate With or Without Entinostat Before Surgery in Treating Patients With Endometrioid E
NCT03018249
National Cancer Institute (NCI)EARLY_Phase 1
Active Not RecruitingLevonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyp
NCT02397083
M.D. Anderson Cancer CenterPhase 2
Active Not RecruitingPrediction of Recurrence Among Low Risk Endometrial Cancer Patients
NCT04604613
M.D. Anderson Cancer Center—